26/09/2018

Successful Launch of Mérieux Participations 3, The new growth Capital Fund of Mérieux Equity Partners


Read more

05/09/2018

 Inscripta Announces Strategic Acquisition of Solana Biosciences


Read more

13/08/2018

Ivantis announces FDA approval for its innovative Hydrus Microstent Device for Minimally Invasive Glaucoma Surgery (MIGS)


Read more

13/08/2018

Xeris Pharmaceuticals Announces Second Quarter 2018 Financial Results and Business Highlights


Read more

13/07/2018

Biom’up obtains CE Mark for its HEMOBLASTTM Bellows Laparoscopic Applicator


Read more

12/07/2018

Inscripta Granted Patents for CRISPR Gene-Editing Systems


Read more

28/06/2018

Novacap completes the acquisition of PCI Synthesis and expands its pharmaceutical offering in the U.S.


Read more

25/06/2018

XERIS PHARMACEUTICALS announces positive phase 3 clinical trial data on its investigational ready-to-use Glucagon rescue pen


Read more

20/06/2018

Novacap to expand its pharmaceutical offering in the US with the acquisition of PCI Synthesis


Read more

20/06/2018

Xeris announces pricing of IPO on Nasdaq (ticker symbol: XERS)


Read more

Pages